The recent discovery of the APOE (apolipoprotein E) Christchurch mutation as protective in the face of high amyloid burden and an AD-causative PSEN1 (presenilin 1) mutation represents a germane exemplar for this concept [1]. Here, APOE is linked to Alzheimer disease.